{
    "organizations": [],
    "uuid": "59b1a7f61c6f0fe74fc68746cebe5d850d26c235",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-nanhua-bio-medicine-buys-54-pct-st/brief-nanhua-bio-medicine-buys-54-pct-stake-in-bio-tech-firm-idUSL4N1Q42AS",
    "ord_in_thread": 0,
    "title": "NanHua Bio-medicine buys 54 pct stake in bio-tech firm",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 14 (Reuters) - NanHua Bio-medicine Co Ltd :\n* Says it completed acquisition of 54 percent stake in a Hunan-based bio-tech firm ProMab Biotechnologies Inc\nSource text in Chinese: goo.gl/KNcgvc\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-02-14T12:46:00.000+02:00",
    "crawled": "2018-02-14T12:34:19.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "nanhua",
        "co",
        "ltd",
        "say",
        "completed",
        "acquisition",
        "percent",
        "stake",
        "firm",
        "promab",
        "biotechnology",
        "inc",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}